These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11304529)

  • 1. Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat.
    Rusnati M; Urbinati C; Caputo A; Possati L; Lortat-Jacob H; Giacca M; Ribatti D; Presta M
    J Biol Chem; 2001 Jun; 276(25):22420-5. PubMed ID: 11304529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
    Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
    FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.
    Rusnati M; Tulipano G; Urbinati C; Tanghetti E; Giuliani R; Giacca M; Ciomei M; Corallini A; Presta M
    J Biol Chem; 1998 Jun; 273(26):16027-37. PubMed ID: 9632653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides.
    Rusnati M; Tulipano G; Spillmann D; Tanghetti E; Oreste P; Zoppetti G; Giacca M; Presta M
    J Biol Chem; 1999 Oct; 274(40):28198-205. PubMed ID: 10497173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
    Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
    J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
    Ensoli B; Buonaguro L; Barillari G; Fiorelli V; Gendelman R; Morgan RA; Wingfield P; Gallo RC
    J Virol; 1993 Jan; 67(1):277-87. PubMed ID: 8416373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
    Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
    Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
    Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals.
    Zugmaier G; Lippman ME; Wellstein A
    J Natl Cancer Inst; 1992 Nov; 84(22):1716-24. PubMed ID: 1279186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.
    Rusnati M; Coltrini D; Campioni D; Tanghetti E; Corallini A; Barbanti-Brodano G; Giuliani R; Gibellini D; Presta M
    AIDS; 1997 May; 11(6):727-36. PubMed ID: 9143604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
    Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M
    FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein.
    Rusnati M; Urbinati C; Musulin B; Ribatti D; Albini A; Noonan D; Marchisone C; Waltenberger J; Presta M
    Endothelium; 2001; 8(1):65-74. PubMed ID: 11409852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.
    Urbinati C; Mitola S; Tanghetti E; Kumar C; Waltenberger J; Ribatti D; Presta M; Rusnati M
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2315-20. PubMed ID: 16166568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
    Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
    J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes.
    Zauli G; Gibellini D; Celeghini C; Mischiati C; Bassini A; La Placa M; Capitani S
    J Immunol; 1996 Sep; 157(5):2216-24. PubMed ID: 8757349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.